PMID- 27915978 OWN - NLM STAT- MEDLINE DCOM- 20180116 LR - 20180818 IS - 1875-5631 (Electronic) IS - 1566-5232 (Linking) VI - 16 IP - 4 DP - 2016 TI - Cell Compatibility of an Eposimal Vector Mediated by the Characteristic Motifs of Matrix Attachment Regions. PG - 271-277 LID - 10.2174/1566523216666161202160936 [doi] AB - The characteristic sequence of beta-interferon matrix attachment regions (MARs) can mediate transgene expression via episomal vectors in Chinese hamster ovary (CHO) cells. However, the host cells were from hamster ovaries, which are not suitable target cells for gene therapy. In this study, we aimed to evaluate the suitability of 12 different human cell lines as target cells for gene therapy. We transfected the cells with episomal vectors and obtained colonies stably expressing the vector products after G418 screening. Therefore the stably transfected cells were split into two and further cultured either in the presence or the absence of G418. Flow cytometry was used to observe the positive rate of cell transfection and level of green fluorescent protein (GFP) expression. Plasmid rescue assays, fluorescence in situ hybridization (FISH), and fluorescence quantitative polymerase chain reaction (PCR) were used to investigate the presence and gene copy numbers of plasmid in mammalian cells. The results showed that transfection efficiency and transgene expression levels in A375, Eca-109, and Changliver cells were high. In contrast, transgene silencing was observed in BJ, HSF, and A431 cells, and low expression of the transgene was observed in the other six cell lines. In addition, the plasmid was present in the episomal state in A375, Eca-109, and Chang-liver cells with relatively low copy numbers even under nonselective conditions. Thus, our results provide the first evidence showing transgene expression of an episomal vector mediated by the characteristic motifs of MARs for maintenance of the longterm stability of episomes in different types of cells. CI - Copyright(c) Bentham Science Publishers; For any queries, please email at epub@benthamscience.org. FAU - Wang, Tian-Yun AU - Wang TY FAU - Wang, Li AU - Wang L FAU - Yang, Yu-Xin AU - Yang YX FAU - Zhao, Chun-Peng AU - Zhao CP FAU - Jia, Yan-Long AU - Jia YL FAU - Li, Qin AU - Li Q FAU - Zhang, Jun-He AU - Zhang JH FAU - Peng, Yi-You AU - Peng YY FAU - Wang, Miao AU - Wang M FAU - Xu, Hong-Yan AU - Xu HY FAU - Wang, Xiao-Yin AU - Wang XY AD - Department of Biochemistry and Molecular Biology, Xinxiang Medical University, Jinsui Road, Xinxiang 453003, Henan, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United Arab Emirates TA - Curr Gene Ther JT - Current gene therapy JID - 101125446 RN - 0 (Recombinant Proteins) RN - 0 (enhanced green fluorescent protein) RN - 147336-22-9 (Green Fluorescent Proteins) SB - IM MH - Animals MH - Cell Line MH - Gene Dosage MH - Genetic Vectors/*genetics MH - Green Fluorescent Proteins/genetics/metabolism MH - Humans MH - In Situ Hybridization, Fluorescence MH - Matrix Attachment Regions/*genetics MH - Plasmids/genetics MH - Recombinant Proteins/genetics/*metabolism MH - Transfection/methods OTO - NOTNLM OT - Eposimal vector OT - Host cell OT - Matrix attachment regions OT - Transgene expression EDAT- 2016/12/06 06:00 MHDA- 2018/01/18 06:00 CRDT- 2016/12/06 06:00 PHST- 2016/05/20 00:00 [received] PHST- 2016/11/02 00:00 [revised] PHST- 2016/11/18 00:00 [accepted] PHST- 2016/12/06 06:00 [pubmed] PHST- 2018/01/18 06:00 [medline] PHST- 2016/12/06 06:00 [entrez] AID - CGT-EPUB-80118 [pii] AID - 10.2174/1566523216666161202160936 [doi] PST - ppublish SO - Curr Gene Ther. 2016;16(4):271-277. doi: 10.2174/1566523216666161202160936.